[Pseudolymphomatous facial folliculitis in a child: hypochromic appearance]

Ann Dermatol Venereol. 2008 Nov;135(11):765-8. doi: 10.1016/j.annder.2008.05.017. Epub 2008 Aug 30.
[Article in French]

Abstract

Background: The entity called pseudolymphomatous folliculitis (PLF) is a cutaneous pseudolymphoma. We report a new case of PLF with an atypical clinical presentation.

Case report: A 6-year-old child was examined for an asymptomatic, hypochromic lesion of the face progressing for three months. The histology showed the activated pilosebaceous units with characteristic perifollicular infiltration by T-cells associated with dendritic cells expressing CD1a and protein S100. The outcome was spontaneously favourable. All of the foregoing elements supported a diagnosis of PLF.

Discussion: PLF is defined as a clinical-pathological entity among the cutaneous pseudolymphomas. The usual clinical aspect is that of a solitary red-to-violaceous asymptomatic nodule measuring less than 1.5cm in diameter. Histology shows follicular invasion characterized by lymphocytic infiltration into pilosebaceous units, creating architectural distortion; this infiltration is associated to perifollicular dendritic cells expressing CD1a and protein S100. We report this new case of PLF because of its peculiar clinical presentation. However, FPL remains a controversial entity, since the follicular location of the pseudolymphomatous lymphocytic infiltration seems poorly specific in facial lesions.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Amoxicillin / therapeutic use*
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / pathology
  • Child
  • Dendritic Cells / immunology
  • Dendritic Cells / pathology
  • Disease Progression
  • Folliculitis / drug therapy
  • Folliculitis / immunology
  • Folliculitis / pathology*
  • Humans
  • Inflammation / pathology
  • Male
  • Pseudolymphoma / drug therapy
  • Pseudolymphoma / immunology
  • Pseudolymphoma / pathology*
  • Skin Diseases / drug therapy
  • Skin Diseases / immunology
  • Skin Diseases / pathology*

Substances

  • Amoxicillin